Literature DB >> 17658407

Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia.

Brent L Wood1.   

Abstract

As hematopoietic cells proceed in differentiation from stem cells to committed progenitors to later stage mature forms, they undergo a sequence of morphologic, immunophenotypic, and functional changes that are a consequence of interaction between the underlying cellular genetic program and environmental cues, are linear for each cell lineage, and result in a pattern of antigenic expression related to lineage and stage of maturation. The antigenic patterns characteristic of normal maturation have been elucidated systematically and found invariant between individuals. Deviation from this pattern is a hallmark of hematopoietic neoplasia. Application of these principles to myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia is presented and illustrated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17658407     DOI: 10.1016/j.cll.2007.05.006

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  13 in total

1.  Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.

Authors:  Roland B Walter; Ted A Gooley; Brent L Wood; Filippo Milano; Min Fang; Mohamed L Sorror; Elihu H Estey; Alexander I Salter; Emily Lansverk; Jason W Chien; Ajay K Gopal; Frederick R Appelbaum; John M Pagel
Journal:  J Clin Oncol       Date:  2011-01-31       Impact factor: 44.544

Review 2.  A chromatic explosion: the development and future of multiparameter flow cytometry.

Authors:  Pratip K Chattopadhyay; Carl-Magnus Hogerkorp; Mario Roederer
Journal:  Immunology       Date:  2008-12       Impact factor: 7.397

3.  Does a diagnosis of myelogenous leukemia require 20% marrow myeloblasts, and does <5% marrow myeloblasts represent a remission? The history and ambiguity of arbitrary diagnostic boundaries in the understanding of myelodysplasia.

Authors:  Marshall A Lichtman
Journal:  Oncologist       Date:  2013-08-27

4.  Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.

Authors:  Min Fang; Barry Storer; Brent Wood; Boglarka Gyurkocza; Brenda M Sandmaier; Frederick R Appelbaum
Journal:  Cancer       Date:  2011-09-16       Impact factor: 6.860

5.  Methods for the identification, characterization and banking of human DPSCs: current strategies and perspectives.

Authors:  Virginia Tirino; Francesca Paino; Riccardo d'Aquino; Vincenzo Desiderio; Alfredo De Rosa; Gianpaolo Papaccio
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

Review 6.  Minimal residual disease in acute myeloid leukaemia.

Authors:  Christopher S Hourigan; Judith E Karp
Journal:  Nat Rev Clin Oncol       Date:  2013-06-25       Impact factor: 66.675

7.  Parthenolide Induces Apoptosis in Committed Progenitor AML Cell line U937 via Reduction in Osteopontin.

Authors:  Mahdi Zahedpanah; Mojgan Shaiegan; Seyed Hamidollah Ghaffari; Mohsen Nikbakht; Mahin Nikugoftar; Saeed Mohammadi
Journal:  Rep Biochem Mol Biol       Date:  2016-04

8.  The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia.

Authors:  Ana Paula Alegretti; Christina Matzenbacher Bittar; Rosane Bittencourt; Amanda Kirchner Piccoli; Laiana Schneider; Lúcia Mariano Silla; Suzane Dal Bó; Ricardo Machado Xavier
Journal:  Rev Bras Hematol Hemoter       Date:  2011

9.  Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome.

Authors:  Moreno Festuccia; H Joachim Deeg; Theodore A Gooley; Kelsey Baker; Brent L Wood; Min Fang; Brenda M Sandmaier; Bart L Scott
Journal:  Biol Blood Marrow Transplant       Date:  2016-04-06       Impact factor: 5.742

10.  Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.

Authors:  Arjan A van de Loosdrecht; Canan Alhan; Marie Christine Béné; Matteo G Della Porta; Angelika M Dräger; Jean Feuillard; Patricia Font; Ulrich Germing; Detlef Haase; Christa H Homburg; Robin Ireland; Joop H Jansen; Wolfgang Kern; Luca Malcovati; Jeroen G Te Marvelde; Ghulam J Mufti; Kiyoyuki Ogata; Alberto Orfao; Gert J Ossenkoppele; Anna Porwit; Frank W Preijers; Stephen J Richards; Gerrit Jan Schuurhuis; Dolores Subirá; Peter Valent; Vincent H J van der Velden; Paresh Vyas; August H Westra; Theo M de Witte; Denise A Wells; Michael R Loken; Theresia M Westers
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.